Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

ClinicalTrials.gov ID: NCT02741596

Public ClinicalTrials.gov record NCT02741596. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

HELP Study ExtensionTM: An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of DX-2930 for Prevention Against Acute Attacks of Hereditary Angioedema (HAE)

Study identification

NCT ID
NCT02741596
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shire
Industry
Enrollment
212 participants

Conditions and interventions

Interventions

  • DX-2930 Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 25, 2016
Primary completion
Oct 30, 2019
Completion
Oct 30, 2019
Last update posted
Jun 7, 2021

2016 – 2019

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
31
Facility City State ZIP Site status
Clinical Research Center of Alabama Birmingham Alabama 35209
Medical Research of Arizona Scottsdale Arizona 85251
University of California San Diego San Diego California 92122
AIRE Medical of Los Angeles Santa Monica California 90404
Allergy & Asthma Clinical Research Walnut Creek California 94598
IMMUNOe Research Centers Centennial Colorado 80112
Asthma and Allergy Associates, PC Colorado Springs Colorado 80907
University of South Florida Tampa Florida 33613
University of Kansas Medical Center Kansas City Kansas 66160
Institute Asthma and Allergy Chevy Chase Maryland 20815
Massachusetts General Hospital Boston Massachusetts 02421
University of Michigan Ann Arbor Michigan 48106
Midwest Immunology Clinic Plymouth Minnesota 55446
Washington University School of Medicine St Louis Missouri 63110
Hudson-Essex Allergy, LLC Belleville New Jersey 07109
Atlantic Research Center, LLC Ocean City New Jersey 07712
Winthrop University Hospital Mineola New York 11501
Icahn School of Medicine at Mount Sinai New York New York 10029
Clinical Research Center of Charlotte Charlotte North Carolina 28277
Duke Asthma, Allergy, and Airway Center Durham North Carolina 27705
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45231
Optimed Research, LTD. Columbus Ohio 43235
Toledo Institute of Clinical REsearch Toledo Ohio 43617
Penn State Hershey Medical Center Hershey Pennsylvania 17033
Austin Regional Clinic Austin Texas 78731
AARA Research Center Dallas Texas 75231
Intermountain Clinical Research Draper Utah 84020
Allergy Associates of Utah Murray Utah 84107
Virginia Commonwealth University Richmond Virginia 23219
Premier Clinical Research Spokane Washington 99202
Medical College of Wisconsin, Childrens Hospital Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02741596, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 7, 2021 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02741596 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →